Tissue Dynamics is a biotechnology company that is committed to fundamentally transforming drug and cosmetic development by advancing next-generation organ on chip (OOC) tools for the pharmaceutical, nutraceutical, and cosmetic industries. The company is focused on disrupting the drug development landscape, by dramatically increasing clinical success rates using human-relevant models and sensor-driven discovery.
Its bionic OOC platform provides critical tools for faster, safer, and more effective drug development while substantially cutting research and development costs. The novel design of Tissue Dynamics sensor-integrated organ tissues presents a quantum leap over existing OOC technologies.
The platforms 3D microphysiological models emulate critical aspects of human physiology while endowing the user with a real-time monitoring system that analyzes the data using a smart algorithm, enabling a revolutionary new understanding of the tissue dynamics.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Tissue Dynamics Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 2, 2026
www.prnewswire.com
/PRNewswire/ -- Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company...
null
May 6, 2026
www.prnewswire.com
/PRNewswire/ -- Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for...
null
Feb 26, 2024
www.businesswire.com
ATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
/PRNewswire/ -- Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company...
null
May 6, 2026
www.prnewswire.com
/PRNewswire/ -- Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for...
null
Feb 26, 2024
www.businesswire.com
ATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market